Fundamental Study of Behaviors of In-Source Collision Induced Dissociation and Shifting the Linear Range of Calibration Curves of Various Drugs and the Metabolites Used for Therapeutic Drug Monitoring

Masamitsu Maekawa, Taku Tsukamoto, Shinya Takasaki, M. Kikuchi, Yu Sato, Jiro Ogura, Yoshihiro Hayakawa, Hiroaki Yamaguchi, N. Mano
{"title":"Fundamental Study of Behaviors of In-Source Collision Induced Dissociation and Shifting the Linear Range of Calibration Curves of Various Drugs and the Metabolites Used for Therapeutic Drug Monitoring","authors":"Masamitsu Maekawa, Taku Tsukamoto, Shinya Takasaki, M. Kikuchi, Yu Sato, Jiro Ogura, Yoshihiro Hayakawa, Hiroaki Yamaguchi, N. Mano","doi":"10.15583/jpchrom.2019.009","DOIUrl":null,"url":null,"abstract":"Therapeutic drug monitoring (TDM) is a clinical practice that designs personalized medication for patients with blood concentrations of the drug. TDM approach is used for many drugs, including immunosuppressant, antifungal, antiarrhythmic, and anti-cancer drugs. Combination therapies are often adopted in TDM. Liquid chromatography tandem mass spectrometry (LC-MS/MS) is a useful analytical method in such cases. However, the development of a simultaneous LC-MS/MS analytical method is difficult owing to the differences in MS sensitivity and the therapeutic range of each drug. In order to avoid saturation of the detector, in-source collision induced dissociation (CID) was used to reduce the ion inlet. In this study, we investigated the in-source CID behavior of 13 compounds of drugs and metabolites in TDM practice. As a result, all compounds provided a sharp reduction of ion inlet over the threshold ion guide voltage. In addition, a shift to the higher concentration of the calibration range was observed according to such changes. The intensity and linearity data in this study that all 13 drugs could be analyzed under in-source CID conditions simultaneously. These results might be useful for TDM of combination therapy in clinical practice.","PeriodicalId":91226,"journal":{"name":"Chromatography (Basel)","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.15583/jpchrom.2019.009","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chromatography (Basel)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15583/jpchrom.2019.009","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3

Abstract

Therapeutic drug monitoring (TDM) is a clinical practice that designs personalized medication for patients with blood concentrations of the drug. TDM approach is used for many drugs, including immunosuppressant, antifungal, antiarrhythmic, and anti-cancer drugs. Combination therapies are often adopted in TDM. Liquid chromatography tandem mass spectrometry (LC-MS/MS) is a useful analytical method in such cases. However, the development of a simultaneous LC-MS/MS analytical method is difficult owing to the differences in MS sensitivity and the therapeutic range of each drug. In order to avoid saturation of the detector, in-source collision induced dissociation (CID) was used to reduce the ion inlet. In this study, we investigated the in-source CID behavior of 13 compounds of drugs and metabolites in TDM practice. As a result, all compounds provided a sharp reduction of ion inlet over the threshold ion guide voltage. In addition, a shift to the higher concentration of the calibration range was observed according to such changes. The intensity and linearity data in this study that all 13 drugs could be analyzed under in-source CID conditions simultaneously. These results might be useful for TDM of combination therapy in clinical practice.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
源内碰撞诱导解离行为的基础研究及用于治疗药物监测的各种药物和代谢物校准曲线线性范围的移动
治疗药物监测(TDM)是一种临床实践,为血液中药物浓度较高的患者设计个性化药物。TDM方法用于许多药物,包括免疫抑制剂、抗真菌药物、抗心律失常药物和抗癌药物。TDM中经常采用联合疗法。在这种情况下,液相色谱-串联质谱法(LC-MS/MS)是一种有用的分析方法。然而,由于MS敏感性和每种药物的治疗范围不同,开发同时进行LC-MS/MS分析的方法是困难的。为了避免探测器饱和,使用了源内碰撞诱导离解(CID)来减少离子入口。在本研究中,我们调查了13种药物和代谢产物化合物在TDM实践中的来源CID行为。结果,所有化合物都提供了超过阈值离子引导电压的离子入口的急剧减少。此外,根据这种变化,观察到向校准范围的较高浓度的转移。本研究中的强度和线性数据表明,所有13种药物都可以在源内CID条件下同时进行分析。这些结果可能有助于TDM的联合治疗在临床实践中的应用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Determination of L-Carnitine and Acetyl-L-carnitine in Aspergillus oryzae- Fermented Rice Bran Product by Hydrophobic Derivatization–LC/ESI-MS/MS Development of Systematic Separation Method of the Ingredients Containing in Crude Aloin Using Countercurrent Chromatography Current Bioanalysis of Molecularly Targeted Drugs Using Liquid Chromatography–Tandem Mass Spectrometry Residual Analysis of Aflatoxin M1 in Cheese by HPLC Coupled with Solid Phase Dispersive Extraction and Solid-Phase Fluorescence Derivatization Method, and Its Accuracy Management for Method Validation Effects of Enteral Formulas and Their Food Protein and Dietary Fiber Components on Postprandial Plasma Warfarin Concentration in Rats
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1